Skip to main content
Premium Trial:

Request an Annual Quote

Ronald Faris, Andrea Grant, and Jerry Williamson

Premium

Ronald Faris has been promoted to senior vice president of MultiCell Technologies, the Warwick, RI-based company announced last week.

MultiCell said that Faris will also retain his role as chief science officer and chairman of the company’s scientific advisory board. Faris has been employed by MultiCell since 1999. He is also an associate professor of pathology and pediatrics at Brown University and Rhode Island Hospital. He earned his PhD in nutritional toxicology from Cornell University, and held a postdoctoral fellowship at the MD Anderson Science Park Research Center.


Andrea Grant has been appointed as managing director of Galadeno, the new service unit of Galapagos Genomics, the Mechelen, Belgium-based company said last week (see News Scan, in this issue). Grant used to be Galapagos’ director of business development.


Jerry Williamson has been appointed as the new president of Biacore, replacing Thomas Wida, who is leaving the company, Biacore International said last week. Williamson joins the Uppsala, Sweden-based company from Beacon BioPartners, a consultancy focusing on the life sciences sector. Until recently, he was the president of Pyrosequencing.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.